NCT07750444Active, not recruiting
Underweight, Overweight, and Linear Growth of Childhood Cancer Patients - the Growth Study
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The Growth study investigates nutritional status, BMI, and linear growth trajectories from birth to adulthood in childhood cancer patients and survivors. Specifically, it aims to identify the predictors driving these distinct growth and weight trajectories and evaluate the consistency of these findings across multiple European countries. The study will make use of routine collected clinical data from oncology centres. Additional information about diagnoses, treatments, sociodemographic, and lifestyle data are obtained by linkages with disease and population registries, and with previously conducted questionnaire studies among survivors. The study will provide insights into the nutritional status of childhood cancer patients and survivors and improve understanding of growth patterns in this population.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 12150 (estimated)
- First submitted
- 13 Jul 2026
- Start date
- 1 Oct 2025
- Primary completion date
- Nov 2027
- Lead sponsor
- Fabiën Belle
- Diseases
- Obesity, Childhood cancers
- NCT number
- NCT07750444
What you commit to
- Study type: Observational
- Planned participants: 12150
- From 1 Oct 2025 to the primary completion date, Nov 2027
- 11 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Diagnosed with cancer at age \<20 years
- Diagnosed between 2004 and 2026
- Treated in one of the participating cancer centres:
- Switzerland: patients who visited one of the cancer centres in Switzerland: Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, St. Gallen, Zurich.
- Portugal: patients diagnosed between 2012-2026 at the Portuguese paediatric oncology centres Instituto Português de Oncologia do Porto Francisco Gentil - IPO-PORTO or at the Instituto Português de Oncologia Francisco Gentil - IPOLFG.
- Slovenia: patients diagnosed between 2011-2026 at the paediatric oncology clinic University Medical Center Ljubljana.
Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kantonsspital Aarau AG Coordinator of this site? Confirm its status | Aarau | Switzerland | Unknown status |
| Universitäts-Kinderspital beider Basel (UKBB) Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
| Ospedale Regionale Di Bellinzona Coordinator of this site? Confirm its status | Bellinzona | Switzerland | Unknown status |
| Kinderklinik, Inselspital Bern Coordinator of this site? Confirm its status | Bern | Switzerland | Unknown status |
| Institute of Social and Preventive Medicine (ISPM), Universität Bern Coordinator of this site? Confirm its status | Bern | Switzerland | Unknown status |
| Hôpitaux Universitaires de Genève (HUG) Coordinator of this site? Confirm its status | Geneva | Switzerland | Unknown status |
| Centre Hospitalier Universitaire Vaudois (CHUV) Coordinator of this site? Confirm its status | Lausanne | Switzerland | Unknown status |
| Kinderspital Zentralschweiz, Luzern Coordinator of this site? Confirm its status | Lucerne | Switzerland | Unknown status |
| HOCH Health Ostschweiz - Kantonsspital St. Gallen Coordinator of this site? Confirm its status | Sankt Gallen | Switzerland | Unknown status |
| Ostschweizer Kinderspital Coordinator of this site? Confirm its status | Sankt Gallen | Switzerland | Unknown status |
| Kinderspital Zürich Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.